InMubadalaVenturesbyAmy Liu·Jul 28, 2023The next frontier of precision medicine — editing the epigenomeGene editing has taken the biotech world by storm since the initial discovery of CRISPR-Cas9, which holds the promise of a potential…
InMubadalaVenturesbyAmy Liu·Mar 22, 2023Building EpiBiologics: Mubadala’s company creation strategyBy Alaa Halawa and Amy Liu